Markets:

Overview

News

Currencies

International

Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

14.87 +0.26 (+1.78%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Simulations Plus, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

March 13, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus and the University of Bath Awarded New FDA Grant

March 05, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Extends Collaboration with Major Toxicology Research Agency

February 15, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Nurtures Growth and Provides Investors with Value. ↗

February 05, 2024

Via Benzinga

Simulations Plus Launches Corporate Development Initiative

February 13, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Participate in Upcoming Healthcare Conferences

February 06, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Releases GastroPlus® Version 9.9

January 30, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus: Dividend Insights ↗

January 23, 2024

Via Benzinga

Simulations Plus: Q1 Earnings Insights ↗

January 03, 2024

Via Benzinga

Earnings Preview: Simulations Plus ↗

January 02, 2024

Via Benzinga

Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant

January 09, 2024

From Simulations Plus, Inc.

Via Business Wire

SLP Stock Earnings: Simulations Plus Meets EPS, Beats Revenue for Q1 2024 ↗

January 03, 2024

SLP stock results show that Simulations Plus met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Simulations Plus Reports First Quarter Fiscal 2024 Financial Results

January 03, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth

January 03, 2024

From Simulations Plus, Inc.

Via Business Wire

Stable Payouts, Increasing Performance: Simulations Plus Supports Investors with Growing Earnings ↗

November 06, 2023

Via Benzinga

Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date

December 20, 2023

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Outlines Paths to Win at 2023 Investor Day

November 14, 2023

From Simulations Plus, Inc.

Via Business Wire

ISoP New Board of Trustees Members Announced

November 08, 2023

From Simulations Plus, Inc.

Via Business Wire

Earnings Scheduled For October 25, 2023 ↗

October 25, 2023

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.

Via Benzinga

Simulations Plus Earnings Preview ↗

October 24, 2023

Via Benzinga

Simulations Plus to Host Investor Day on Tuesday, November 14th

October 31, 2023

From Simulations Plus, Inc.

Via Business Wire

Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 26, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 25, 2023

Via Benzinga

Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results

October 25, 2023

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

October 11, 2023

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Receives New FDA Grant Award

September 21, 2023

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors

September 07, 2023

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)

August 24, 2023

From Simulations Plus, Inc.

Via Business Wire

Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment

August 15, 2023

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Releases ADMET Predictor® 11

July 13, 2023

From Simulations Plus, Inc.

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.